{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:52:12Z","timestamp":1792687932586,"version":"4.5.0"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,9,25]],"date-time":"2012-09-25T00:00:00Z","timestamp":1348531200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1038\/nrrheum.2012.156","type":"journal-article","created":{"date-parts":[[2012,9,25]],"date-time":"2012-09-25T06:40:43Z","timestamp":1348555243000},"page":"79-89","source":"Crossref","is-referenced-by-count":62,"title":["Differential diagnosis and management of Beh\u00e7et syndrome"],"prefix":"10.1038","volume":"9","author":[{"given":"Nicola L.","family":"Ambrose","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorian O.","family":"Haskard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,9,25]]},"reference":[{"key":"BFnrrheum2012156_CR1","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1136\/bjo.40.6.355","volume":"40","author":"A Feigenbaum","year":"1956","unstructured":"Feigenbaum, A. Description of Beh\u00e7et's syndrome in the Hippocratic third book of endemic diseases. Br. J. Ophthalmol. 40, 355\u2013357 (1956).","journal-title":"Br. J. Ophthalmol."},{"key":"BFnrrheum2012156_CR2","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1046\/j.1523-1747.2002.01798.x","volume":"119","author":"CC Zouboulis","year":"2002","unstructured":"Zouboulis, C. C. & Keitel, W. A historical review of early descriptions of Adamantiades-Beh\u00e7et's disease. J. Invest. Dermatol. 119, 201\u2013205 (2002).","journal-title":"J. Invest. Dermatol."},{"key":"BFnrrheum2012156_CR3","unstructured":"Adamantiades, B. A case of relapsing iritis with hypopyon [Greek]. Archia Iatrikis Etairias, (Proceedings of the Medical Society of Athens) Athens, 586\u2013593 (1930)."},{"key":"BFnrrheum2012156_CR4","first-page":"1152","volume":"105","author":"H Beh\u00e7et","year":"1937","unstructured":"Beh\u00e7et, H. \u00dcber rezidivierende aphthose, durch ein virus verursachte geschw\u00fcre am mund, am auge und an der genitalien [German]. Dermatol. Wochenschr. 105, 1152\u20131157 (1937).","journal-title":"Dermatol. Wochenschr."},{"key":"BFnrrheum2012156_CR5","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/ng.624","volume":"42","author":"N Mizuki","year":"2010","unstructured":"Mizuki, N. et al. Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Beh\u00e7et's disease susceptibility loci. Nat. Genet. 42, 703\u2013706 (2010).","journal-title":"Nat. Genet."},{"key":"BFnrrheum2012156_CR6","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/ng.625","volume":"42","author":"EF Remmers","year":"2010","unstructured":"Remmers, E. F. et al. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Beh\u00e7et's disease. Nat. Genet. 42, 698\u2013702 (2010).","journal-title":"Nat. Genet."},{"key":"BFnrrheum2012156_CR7","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1136\/ard.60.11.996","volume":"60","author":"H Direskeneli","year":"2001","unstructured":"Direskeneli, H. Beh\u00e7et's disease: infectious aetiology, new autoantigens, and HLA-B51. Ann. Rheum. Dis. 60, 996\u20131002 (2001).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2012156_CR8","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s10067-010-1491-6","volume":"29","author":"VD Kapsimali","year":"2010","unstructured":"Kapsimali, V. D., Kanakis, M. A., Vaiopoulos, G. A. & Kaklamanis, P. G. Etiopathogenesis of Beh\u00e7et's disease with emphasis on the role of immunological aberrations. Clin. Rheumatol. 29, 1211\u20131216 (2010).","journal-title":"Clin. Rheumatol."},{"key":"BFnrrheum2012156_CR9","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1056\/NEJMra010200","volume":"345","author":"JP Drenth","year":"2001","unstructured":"Drenth, J. P. & van der Meer, J. W. Hereditary periodic fever. N. Engl. J. Med. 345, 1748\u20131757 (2001).","journal-title":"N. Engl. J. Med."},{"key":"BFnrrheum2012156_CR10","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2174\/1568010053622894","volume":"4","author":"A Gul","year":"2005","unstructured":"Gul, A. Beh\u00e7et's disease as an autoinflammatory disorder. Curr. Drug Targets Inflamm. Allergy 4, 81\u201383 (2005).","journal-title":"Curr. Drug Targets Inflamm. Allergy"},{"key":"BFnrrheum2012156_CR11","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1034\/j.1399-0039.1999.540301.x","volume":"54","author":"DH Verity","year":"1999","unstructured":"Verity, D. H., Marr, J. E., Ohno, S., Wallace, G. R. & Stanford, M. R. Beh\u00e7et's disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens 54, 213\u2013220 (1999).","journal-title":"Tissue Antigens"},{"key":"BFnrrheum2012156_CR12","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1097\/00005792-200301000-00006","volume":"82","author":"E Kural-Seyahi","year":"2003","unstructured":"Kural-Seyahi, E. et al. The long-term mortality and morbidity of Beh\u00e7et syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore) 82, 60\u201376 (2003).","journal-title":"Medicine (Baltimore)"},{"key":"BFnrrheum2012156_CR13","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/j.1756-185X.2010.01549.x","volume":"13","author":"F Davatchi","year":"2010","unstructured":"Davatchi, F. et al. Beh\u00e7et's disease in Iran: analysis of 6500 cases. Int. J. Rheum. Dis. 13, 367\u2013373 (2010).","journal-title":"Int. J. Rheum. Dis."},{"key":"BFnrrheum2012156_CR14","first-page":"145","volume-title":"Beh\u00e7et's Disease","author":"K Nakae","year":"1993","unstructured":"Nakae, K. et al. in Beh\u00e7et's Disease (eds Godeau, P. & Wechsler, B.) 145\u2013151 (Excerpta Medica, Amsterdam, 1993)."},{"key":"BFnrrheum2012156_CR15","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1479-8077.2006.00208.x","volume":"9","author":"Z Zhang","year":"2006","unstructured":"Zhang, Z., Peng, J., Hou, X. & Dong, Y. Clinical manifestations of Beh\u00e7et's Disease in Chinese patients. APLAR J. Rheumatol. 9, 244\u2013247 (2006).","journal-title":"APLAR J. Rheumatol."},{"key":"BFnrrheum2012156_CR16","doi-asserted-by":"publisher","first-page":"615","DOI":"10.3346\/jkms.2001.16.5.615","volume":"16","author":"D Bang","year":"2001","unstructured":"Bang, D. et al. Epidemiologic and clinical survey of Beh\u00e7et's disease in Korea: the first multicenter study. J. Korean Med. Sci. 16, 615\u2013618 (2001).","journal-title":"J. Korean Med. Sci."},{"key":"BFnrrheum2012156_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1610-0387.2006.05841.x","volume":"4","author":"A Altenburg","year":"2006","unstructured":"Altenburg, A. et al. Epidemiology and clinical manifestations of Adamantiades-Beh\u00e7et disease in Germany\u2013current pathogenetic concepts and therapeutic possibilities [German]. J. Dtsch Dermatol. Ges. 4, 49\u201364 (2006).","journal-title":"J. Dtsch Dermatol. Ges."},{"key":"BFnrrheum2012156_CR18","first-page":"820","volume":"15","author":"S Yurdakul","year":"1988","unstructured":"Yurdakul, S. et al. The prevalence of Beh\u00e7et's syndrome in a rural area in northern Turkey. J. Rheumatol. 15, 820\u2013822 (1988).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum2012156_CR19","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1046\/j.1365-4362.2003.01893.x","volume":"42","author":"G Azizlerli","year":"2003","unstructured":"Azizlerli, G. et al. Prevalence of Beh\u00e7et's disease in Istanbul, Turkey. Int. J. Dermatol. 42, 803\u2013806 (2003).","journal-title":"Int. J. Dermatol."},{"key":"BFnrrheum2012156_CR20","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1136\/ard.36.6.491","volume":"36","author":"MA Chamberlain","year":"1977","unstructured":"Chamberlain, M. A. Beh\u00e7et's syndrome in 32 patients in Yorkshire. Ann. Rheum. Dis. 36, 491\u2013499 (1977).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2012156_CR21","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/art.24423","volume":"15","author":"KT Calamia","year":"2009","unstructured":"Calamia, K. T. et al. Epidemiology and clinical characteristics of Beh\u00e7et's disease in the US: a population-based study. Arthritis Rheum. 15, 600\u2013604 (2009).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2012156_CR22","first-page":"1384","volume":"35","author":"F Davatchi","year":"2008","unstructured":"Davatchi, F. et al. WHO-ILAR COPCORD Study (Stage 1, Urban Study) in Iran J. Rheumatol. 35, 1384 (2008).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum2012156_CR23","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/00002281-200401000-00008","volume":"16","author":"S Yurdakul","year":"2004","unstructured":"Yurdakul, S., Hamuryudan, V. & Yazici, H. Beh\u00e7et syndrome. Curr. Opin. Rheumatol. 16, 38\u201342 (2004).","journal-title":"Curr. Opin. Rheumatol."},{"key":"BFnrrheum2012156_CR24","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1093\/rheumatology\/keq251","volume":"49","author":"E Bernab\u00e9","year":"2010","unstructured":"Bernab\u00e9, E., Marcenes, W., Mather, J., Phillips, C. & Fortune, F. Impact of Beh\u00e7et's syndrome on health-related quality of life: influence of the type and number of symptoms. Rheumatology (Oxford) 49, 2165\u20132171 (2010).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrrheum2012156_CR25","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3349\/ymj.1997.38.6.423","volume":"38","author":"A Gurler","year":"1997","unstructured":"Gurler, A., Boyvat, A. & T\u00fcrsen, U. Clinical manifestations of Beh\u00e7et's disease: an analysis of 2147 patients. Yonsei Med. J. 38, 423\u2013427 (1997).","journal-title":"Yonsei Med. J."},{"key":"BFnrrheum2012156_CR26","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.jaad.2007.10.452","volume":"58","author":"Y Karincaoglu","year":"2008","unstructured":"Karincaoglu, Y. et al. Demographic and clinical properties of juvenile-onset Beh\u00e7et's disease: A controlled multicenter study. J. Am. Acad. Dermatol. 58, 579\u2013584 (2008).","journal-title":"J. Am. Acad. Dermatol."},{"key":"BFnrrheum2012156_CR27","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1007\/s100670070020","volume":"19","author":"M Soy","year":"2000","unstructured":"Soy, M., Erken, E., Konca, K. & Ozbek, S. Smoking and Beh\u00e7et's disease. Clin. Rheumatol. 19, 508\u2013509 (2000).","journal-title":"Clin. Rheumatol."},{"key":"BFnrrheum2012156_CR28","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1136\/ard.60.11.1074","volume":"60","author":"E Diri","year":"2001","unstructured":"Diri, E. et al. Papulopustular skin lesions are seen more frequently in patients with Beh\u00e7et's syndrome who have arthritis: a controlled and masked study. Ann. Rheum. Dis. 60, 1074\u20131076 (2001).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2012156_CR29","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1136\/ard.2003.017467","volume":"63","author":"G Hatemi","year":"2004","unstructured":"Hatemi, G. et al. The pustular skin lesions in Beh\u00e7et's syndrome are not sterile. Ann. Rheum. Dis. 63, 1450\u20131452 (2004).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2012156_CR30","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.ajo.2004.03.022","volume":"138","author":"I Tugal-Tutkun","year":"2004","unstructured":"Tugal-Tutkun, I., Onal, S., Altan-Yaycioglu, R., Huseyin Altunbas, H. & Urgancioglu, M. Uveitis in Beh\u00e7et disease: an analysis of 880 patients. Am. J. Ophthalmol. 138, 373\u2013380 (2004).","journal-title":"Am. J. Ophthalmol."},{"key":"BFnrrheum2012156_CR31","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1093\/rheumatology\/kei255","volume":"45","author":"D Kidd","year":"2006","unstructured":"Kidd, D. The prevalence of headache in Beh\u00e7et's syndrome. Rheumatology (Oxford) 45, 621\u2013623 (2006).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrrheum2012156_CR32","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1093\/brain\/122.11.2183","volume":"122","author":"D Kidd","year":"1999","unstructured":"Kidd, D., Steuer, A., Denman, A. M. & Rudge, P. Neurological complications in Beh\u00e7et's syndrome. Brain 122, 2183\u20132194 (1999).","journal-title":"Brain"},{"key":"BFnrrheum2012156_CR33","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1093\/brain\/122.11.2171","volume":"122","author":"G Akman-Demir","year":"1999","unstructured":"Akman-Demir, G., Serdaroglu, P. & Tas\u00e7i, B. Clinical patterns of neurological involvement in Beh\u00e7et's disease: evaluation of 200 patients. The Neuro-Beh\u00e7et Study Group. Brain 122, 2171\u20132182 (1999).","journal-title":"Brain"},{"key":"BFnrrheum2012156_CR34","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jns.2007.09.041","volume":"267","author":"S Hirohata","year":"2008","unstructured":"Hirohata, S. Histopathology of central nervous system lesions in Beh\u00e7et's disease. J. Neurol. Sci. 267, 41\u201347 (2008).","journal-title":"J. Neurol. Sci."},{"key":"BFnrrheum2012156_CR35","first-page":"249","volume":"15","author":"MG Hadfield","year":"1996","unstructured":"Hadfield, M. G., Aydin, F., Lippman, H. R., Kubal, W. S. & Sanders, K. M. Neuro-Beh\u00e7et's disease. Clin. Neuropathol. 15, 249\u2013255 (1996).","journal-title":"Clin. Neuropathol."},{"key":"BFnrrheum2012156_CR36","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s004150170242","volume":"248","author":"A Siva","year":"2001","unstructured":"Siva, A. et al. Beh\u00e7et's disease: diagnostic and prognostic aspects of neurological involvement. J. Neurol. 248, 95\u2013103 (2001).","journal-title":"J. Neurol."},{"key":"BFnrrheum2012156_CR37","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1258\/0022215011908315","volume":"115","author":"L Pollak","year":"2001","unstructured":"Pollak, L., Luxon, L. M. & Haskard, D. O. Labyrinthine involvement in Beh\u00e7et's syndrome. J. Laryngol. Otol. 115, 522\u2013529 (2001).","journal-title":"J. Laryngol. Otol."},{"key":"BFnrrheum2012156_CR38","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1007\/s002340050837","volume":"41","author":"HR J\u00e4ger","year":"1999","unstructured":"J\u00e4ger, H. R., Albrecht, T., Curati-Alasonatti, W. L., Williams, E. J. & Haskard, D. O. MRI in neuro-Beh\u00e7et's syndrome: comparison of conventional spin-echo and FLAIR pulse sequences. Neuroradiology 41, 750\u2013758 (1999).","journal-title":"Neuroradiology"},{"key":"BFnrrheum2012156_CR39","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1001\/archneur.1996.00550070133022","volume":"53","author":"G Akman-Demir","year":"1996","unstructured":"Akman-Demir, G. et al. Seven-year follow-up of neurologic involvement in Beh\u00e7et syndrome. Arch. Neurol. 53, 691\u2013694 (1996).","journal-title":"Arch. Neurol."},{"key":"BFnrrheum2012156_CR40","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/S1474-4422(09)70015-8","volume":"8","author":"A Al-Araji","year":"2009","unstructured":"Al-Araji, A. & Kidd, D. P. Neuro-Beh\u00e7et's disease: epidemiology, clinical characteristics, and management. Lancet Neurol. 8, 192\u2013204 (2009).","journal-title":"Lancet Neurol."},{"key":"BFnrrheum2012156_CR41","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1136\/ard.42.5.505","volume":"42","author":"S Yurdakul","year":"1983","unstructured":"Yurdakul, S. et al. The arthritis of Beh\u00e7et's disease: a prospective study. Ann. Rheum. Dis. 42, 505\u2013515 (1983).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2012156_CR42","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0049-0172(90)90023-9","volume":"20","author":"MA Khan","year":"1990","unstructured":"Khan, M. A. & van der Linden, S. M. A wider spectrum of spondyloarthropathies. Semin. Arthritis Rheum. 20, 107\u2013113 (1990).","journal-title":"Semin. Arthritis Rheum."},{"key":"BFnrrheum2012156_CR43","first-page":"281","volume-title":"Recent Advances in Beh\u00e7et's Disease","author":"N Dilsen","year":"1986","unstructured":"Dilsen N., Konice, M. & Aral, O. in Recent Advances in Beh\u00e7et's Disease (eds Lehner, T. & Barnes, C. G.) 281\u2013284 (Royal Society of Medicine Services, London, 1986)."},{"key":"BFnrrheum2012156_CR44","first-page":"S15","volume":"23","author":"SS Lee","year":"2005","unstructured":"Lee, S. S., Yoon, H. J., Chang, H. K. & Park, K. S. Fibromyalgia in Beh\u00e7et's disease is associated with anxiety and depression, and not with disease activity. Clin. Exp. Rheumatol. 23, S15\u2013S19 (2005).","journal-title":"Clin. Exp. Rheumatol."},{"key":"BFnrrheum2012156_CR45","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/0002-9343(85)90547-9","volume":"79","author":"GS Firestein","year":"1985","unstructured":"Firestein, G. S. et al. Mouth and genital ulcers with inflamed cartilage: MAGIC syndrome. Five patients with features of relapsing polychondritis and Beh\u00e7et's disease. Am. J. Med. 79, 65\u201372 (1985).","journal-title":"Am. J. Med."},{"key":"BFnrrheum2012156_CR46","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1002\/art.24540","volume":"61","author":"M Colina","year":"2009","unstructured":"Colina, M., Govoni, M., Orzincolo, C. & Trotta, F. Clinical and radiologic evolution of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: a single center study of a cohort of 71 subjects. Arthritis Rheum. 61, 813\u2013821 (2009).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2012156_CR47","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1097\/00004836-200003000-00006","volume":"30","author":"Y Bayraktar","year":"2000","unstructured":"Bayraktar, Y., Ozaslan, E. & Van Thiel, D. H. Gastrointestinal manifestations of Beh\u00e7et's disease. J. Clin. Gastroenterol. 30, 144\u2013154 (2000).","journal-title":"J. Clin. Gastroenterol."},{"key":"BFnrrheum2012156_CR48","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/rheumatology\/ken216","volume":"47","author":"SS Hamdulay","year":"2008","unstructured":"Hamdulay, S. S. et al. Wireless capsule endoscopy in the investigation of intestinal Beh\u00e7et's syndrome. Rheumatology (Oxford) 47, 1231\u20131234 (2008).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrrheum2012156_CR49","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1055\/s-0028-1103481","volume":"41","author":"SK Lee","year":"2009","unstructured":"Lee, S. K., Kim, B. K., Kim, T. I. & Kim, W. H. Differential diagnosis of intestinal Beh\u00e7et's disease and Crohn's disease by colonoscopic findings. Endoscopy 41, 9\u201316 (2009).","journal-title":"Endoscopy"},{"key":"BFnrrheum2012156_CR50","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1093\/rheumatology\/keq090","volume":"49","author":"P Mehta","year":"2010","unstructured":"Mehta, P., Laffan, M. & Haskard, D. O. Thrombosis and Beh\u00e7et's syndrome in non-endemic regions. Rheumatology (Oxford) 49, 2003\u20132004 (2010).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrrheum2012156_CR51","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1111\/j.1365-4632.2006.02832.x","volume":"45","author":"R Sarica-Kucukoglu","year":"2006","unstructured":"Sarica-Kucukoglu, R. et al. Vascular involvement in Beh\u00e7et's disease: a retrospective analysis of 2319 cases. Int. J. Dermatol. 45, 919\u2013921 (2006).","journal-title":"Int. J. Dermatol."},{"key":"BFnrrheum2012156_CR52","doi-asserted-by":"publisher","first-page":"e2011026","DOI":"10.4084\/mjhid.2011.026","volume":"3","author":"E Seyahi","year":"2011","unstructured":"Seyahi, E. & Yurdakul, S. Beh\u00e7et's syndrome and thrombosis. Mediterr. J. Hematol. Infect. Dis. 3, e2011026 (2011).","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"issue":"Suppl. 34","key":"BFnrrheum2012156_CR53","first-page":"1","volume":"22","author":"V Hamuryudan","year":"2004","unstructured":"Hamuryudan, V., Oz, B., T\u00fcz\u00fcn, H. & Yazici, H. The menacing pulmonary artery aneurysms of Beh\u00e7et's syndrome. Clin. Exp. Rheumatol. 22 (Suppl. 34), 1\u20133 (2004).","journal-title":"Clin. Exp. Rheumatol."},{"key":"BFnrrheum2012156_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semarthrit.2007.09.009","volume":"38","author":"E Seyahi","year":"2008","unstructured":"Seyahi, E. et al. Atherosclerosis in Beh\u00e7et's syndrome. Semin. Arthritis Rheum. 38, 1\u201312 (2008).","journal-title":"Semin. Arthritis Rheum."},{"key":"BFnrrheum2012156_CR55","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/MD.0b013e3182428f49","volume":"91","author":"G Geri","year":"2012","unstructured":"Geri, G. et al. Spectrum of cardiac lesions in Beh\u00e7et disease: a series of 52 patients and review of the literature. Medicine (Baltimore) 91, 25\u201334 (2012).","journal-title":"Medicine (Baltimore)"},{"key":"BFnrrheum2012156_CR56","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/S0090-4295(98)00341-0","volume":"52","author":"B Cetinel","year":"1998","unstructured":"Cetinel, B., Obek, C., Solok, V., Yaycioglu, O. & Yazici, H. Urologic screening for men with Beh\u00e7et's syndrome. Urology 52, 863\u2013865 (1998).","journal-title":"Urology"},{"key":"BFnrrheum2012156_CR57","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3109\/09273948.2011.634978","volume":"20","author":"A Gul","year":"2012","unstructured":"Gul, A. & Ohno, S. HLA-B*51 and Beh\u00e7et disease. Ocul. Immunol. Inflamm. 20, 37\u201343 (2012).","journal-title":"Ocul. Immunol. Inflamm."},{"key":"BFnrrheum2012156_CR58","doi-asserted-by":"crossref","unstructured":"Criteria for diagnosis of Beh\u00e7et's disease. International Study Group for Beh\u00e7et's Disease. Lancet 335, 1078\u20131080 (1990).","DOI":"10.1016\/0140-6736(90)92643-V"},{"key":"BFnrrheum2012156_CR59","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1136\/ard.43.1.70","volume":"43","author":"PG Davies","year":"1984","unstructured":"Davies, P. G., Fordham, J. N., Kirwan, J. R., Barnes, C. G. & Dinning, W. J. The pathergy test and Beh\u00e7et's syndrome in Britain. Ann. Rheum. Dis. 43, 70\u201373 (1984).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2012156_CR60","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1007\/s10067-011-1694-5","volume":"30","author":"F Davatchi","year":"2011","unstructured":"Davatchi, F. et al. Diagnostic value of pathergy test in Beh\u00e7et's disease according to the change of incidence over the time. Clin. Rheumatol. 30, 1151\u20131155 (2011).","journal-title":"Clin. Rheumatol."},{"key":"BFnrrheum2012156_CR61","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1136\/ard.50.9.634","volume":"50","author":"N Cakir","year":"1991","unstructured":"Cakir, N. et al. Response to intradermal injection of monosodium urate crystals in Beh\u00e7et's syndrome. Ann. Rheum. Dis. 50, 634\u2013636 (1991).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2012156_CR62","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1093\/rheumatology\/37.11.1148","volume":"37","author":"T Budak-Alpdogan","year":"1998","unstructured":"Budak-Alpdogan, T. et al. Skin hyperreactivity of Beh\u00e7et's patients (pathergy reaction) is also positive in interferon alpha-treated chronic myeloid leukaemia patients, indicating similarly altered neutrophil functions in both disorders. Br. J. Rheumatol. 37, 1148\u20131151 (1998).","journal-title":"Br. J. Rheumatol."},{"key":"BFnrrheum2012156_CR63","doi-asserted-by":"publisher","unstructured":"Saenz, A. et al. Pharmacotherapy for Beh\u00e7et's syndrome. Cochrane Database of Systematic Reviews, Issue 2. Art. No.: CD001084. http:\/\/dx.doi.org\/10.1002\/14651858.CD001084 .","DOI":"10.1002\/14651858.CD001084"},{"key":"BFnrrheum2012156_CR64","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1093\/rheumatology\/kei165","volume":"45","author":"C Mat","year":"2006","unstructured":"Mat, C. et al. A double-blind trial of depot corticosteroids in Beh\u00e7et's syndrome. Rheumatology (Oxford) 45, 348\u2013352 (2006).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrrheum2012156_CR65","first-page":"399","volume":"65","author":"E Aktulga","year":"1980","unstructured":"Aktulga, E. et al. A double blind study of colchicine in Beh\u00e7et's disease. Haematologica 65, 399\u2013402 (1980).","journal-title":"Haematologica"},{"key":"BFnrrheum2012156_CR66","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1002\/1529-0131(200111)44:11<2686::AID-ART448>3.0.CO;2-H","volume":"44","author":"S Yurdakul","year":"2001","unstructured":"Yurdakul, S. et al. A double-blind trial of colchicine in Beh\u00e7et's syndrome. Arthritis Rheum. 44, 2686\u20132692 (2001).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2012156_CR67","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1056\/NEJM199002013220501","volume":"322","author":"H Yazici","year":"1990","unstructured":"Yazici, H. et al. A controlled trial of azathioprine in Beh\u00e7et's syndrome. N. Engl. J. Med. 322, 281\u2013285 (1990).","journal-title":"N. Engl. J. Med."},{"key":"BFnrrheum2012156_CR68","first-page":"98","volume":"32","author":"M Melikoglu","year":"2005","unstructured":"Melikoglu, M. et al. Short-term trial of etanercept in Beh\u00e7et's disease: a double blind, placebo controlled study. J. Rheumatol. 32, 98\u2013105 (2005).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum2012156_CR69","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1001\/archderm.138.4.467","volume":"138","author":"E Alpsoy","year":"2002","unstructured":"Alpsoy, E. et al. Interferon alfa-2a in the treatment of Beh\u00e7et disease: a randomized placebo-controlled and double-blind study. Arch. Dermatol. 138, 467\u2013471 (2002).","journal-title":"Arch. Dermatol."},{"key":"BFnrrheum2012156_CR70","doi-asserted-by":"publisher","first-page":"443","DOI":"10.7326\/0003-4819-128-6-199803150-00004","volume":"128","author":"V Hamuryudan","year":"1998","unstructured":"Hamuryudan, V. et al. Thalidomide in the treatment of the mucocutaneous lesions of the Beh\u00e7et syndrome. A randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 128, 443\u2013450 (1998).","journal-title":"Ann. Intern. Med."},{"key":"BFnrrheum2012156_CR71","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/S0140-6736(89)92381-7","volume":"1","author":"K Masuda","year":"1989","unstructured":"Masuda, K. et al. Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Beh\u00e7et's disease. Lancet 1, 1093\u20131096 (1989).","journal-title":"Lancet"},{"key":"BFnrrheum2012156_CR72","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.1346-8138.2002.tb00263.x","volume":"29","author":"KE Sharquie","year":"2002","unstructured":"Sharquie, K. E., Najim, R. A. & Abu-Raghif, A. R. Dapsone in Beh\u00e7et's disease: a double-blind, placebo-controlled, cross-over study. J. Dermatol. 29, 267\u2013279 (2002).","journal-title":"J. Dermatol."},{"key":"BFnrrheum2012156_CR73","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1093\/rheumatology\/27.4.300","volume":"27","author":"UM Davies","year":"1988","unstructured":"Davies, U. M., Palmer, R. G. & Denman, A. M. Treatment with acyclovir does not affect orogenital ulcers in Beh\u00e7et's syndrome: a randomized double-blind trial. Br. J. Rheumatol 27, 300\u2013302 (1988).","journal-title":"Br. J. Rheumatol"},{"key":"BFnrrheum2012156_CR74","first-page":"3","volume":"11","author":"MM Al-Waiz","year":"2005","unstructured":"Al-Waiz, M. M., Sharquie, K. E., A-Qaissi, M. H. & Hayani, R. K. Colchicine and benzathine penicillin in the treatment of Beh\u00e7et disease: a case comparative study. Dermatol. Online J. 11, 3 (2005).","journal-title":"Dermatol. Online J."},{"key":"BFnrrheum2012156_CR75","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/0190-9622(91)70156-V","volume":"24","author":"JL Jorizzo","year":"1991","unstructured":"Jorizzo, J. L., White, W. L., Wise, C. M., Zanolli, M. D. & Sherertz, E. F. Low-dose weekly methotrexate for unusual neutrophilic vascular reactions: cutaneous polyarteritis nodosa and Beh\u00e7et's disease. J. Am. Acad. Dermatol. 24, 973\u2013978 (1991).","journal-title":"J. Am. Acad. Dermatol."},{"key":"BFnrrheum2012156_CR76","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3349\/ymj.2007.48.4.573","volume":"48","author":"E Alpsoy","year":"2007","unstructured":"Alpsoy, E., Zouboulis, C. C. & Ehrlich, G. E. Mucocutaneous lesions of Beh\u00e7et's disease. Yonsei Med. J. 48, 573\u2013585 (2007).","journal-title":"Yonsei Med. J."},{"key":"BFnrrheum2012156_CR77","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/sj.bdj.4803798","volume":"141","author":"M Addy","year":"1976","unstructured":"Addy, M., Carpenter, R. & Roberts, W. R. Management of recurrent aphthous ulceration. A trial of chlorhexidine gluconate gel. Br. Dent. J. 141, 118\u2013120 (1976).","journal-title":"Br. Dent. J."},{"key":"BFnrrheum2012156_CR78","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/0030-4220(91)90553-O","volume":"72","author":"TF Meiller","year":"1991","unstructured":"Meiller, T. F. et al. Effect of an antimicrobial mouthrinse on recurrent aphthous ulcerations. Oral Surg. Oral Med. Oral Pathol. 72, 425\u2013429 (1991).","journal-title":"Oral Surg. Oral Med. Oral Pathol."},{"key":"BFnrrheum2012156_CR79","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1001\/archderm.135.5.529","volume":"135","author":"E Alpsoy","year":"1999","unstructured":"Alpsoy, E., Er, H., Durusoy, C. & Yilmaz, E. The use of sucralfate suspension in the treatment of oral and genital ulceration of Beh\u00e7et disease: a randomized, placebo-controlled, double-blind study. Arch. Dermatol. 135, 529\u2013532 (1999).","journal-title":"Arch. Dermatol."},{"key":"BFnrrheum2012156_CR80","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1001\/archderm.138.4.467","volume":"138","author":"E Alpsoy","year":"2002","unstructured":"Alpsoy, E. et al. Interferon alfa-2a in the treatment of Beh\u00e7et disease: a randomized placebo-controlled and double-blind study. Arch. Dermatol. 138, 467\u2013471 (2002).","journal-title":"Arch. Dermatol."},{"key":"BFnrrheum2012156_CR81","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1002\/acr.20308","volume":"62","author":"D Saadoun","year":"2010","unstructured":"Saadoun, D. et al. Azathioprine in severe uveitis of Beh\u00e7et's disease. Arthritis Care Res. (Hoboken) 62, 1733\u20131738 (2010).","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"BFnrrheum2012156_CR82","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1002\/art.1780400425","volume":"40","author":"V Hamuryudan","year":"1997","unstructured":"Hamuryudan, V. et al. Azathioprine in Beh\u00e7et's syndrome: effects on long-term prognosis. Arthritis Rheum. 40, 769\u2013774 (1997).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2012156_CR83","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s10792-008-9200-z","volume":"29","author":"P Neri","year":"2009","unstructured":"Neri, P., Mariotti, C., Cimino, L., Mercanti, L. & Giovannini, A. Long-term control of cystoid macular oedema in noninfectious uveitis with Mycophenolate Mofetil. Int. Ophthalmol. 29, 127\u2013133 (2009).","journal-title":"Int. Ophthalmol."},{"key":"BFnrrheum2012156_CR84","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1136\/bjo.76.4.241","volume":"76","author":"Y Ozyazgan","year":"1992","unstructured":"Ozyazgan, Y. et al. Low dose cyclosporin A versus pulsed cyclophosphamide in Beh\u00e7et's syndrome: a single masked trial. Br. J. Ophthalmol. 76, 241\u2013243 (1992).","journal-title":"Br. J. Ophthalmol."},{"issue":"3 Suppl. 4","key":"BFnrrheum2012156_CR85","first-page":"122","volume":"20","author":"D BenEzra","year":"1988","unstructured":"BenEzra, D. et al. Treatment of endogenous uveitis with cyclosporine, A. Transplant Proc. 20 (3 Suppl. 4), 122\u2013127 (1988).","journal-title":"Transplant Proc."},{"key":"BFnrrheum2012156_CR86","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.semarthrit.2010.09.002","volume":"41","author":"A Arida","year":"2011","unstructured":"Arida, A., Fragiadaki, K., Giavri, E. & Sfikakis, P. P. Anti-TNF agents for Beh\u00e7et's disease: analysis of published data on 369 patients. Semin. Arthritis Rheum. 41, 61\u201370 (2011).","journal-title":"Semin. Arthritis Rheum."},{"key":"BFnrrheum2012156_CR87","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1590\/S0004-27492010000100007","volume":"73","author":"JM Zaghetto","year":"2010","unstructured":"Zaghetto, J. M. et al. Chlorambucil and cyclosporine A in Brazilian patients with Beh\u00e7et's disease uveitis: a retrospective study. Arq. Bras. Oftalmol. 73, 40\u201346 (2010).","journal-title":"Arq. Bras. Oftalmol."},{"issue":"Suppl. 11","key":"BFnrrheum2012156_CR88","first-page":"928","volume":"4","author":"V Hamuryudan","year":"2002","unstructured":"Hamuryudan, V. et al. Interferon alfa combined with azathioprine for the uveitis of Beh\u00e7et's disease: an open study. Isr. Med. Assoc. J. 4 (Suppl. 11), 928\u2013930 (2002).","journal-title":"Isr. Med. Assoc. J."},{"key":"BFnrrheum2012156_CR89","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1016\/j.ophtha.2009.11.022","volume":"117","author":"G Sobaci","year":"2010","unstructured":"Sobaci, G. et al. Safety and effectiveness of interferon alpha-2a in treatment of patients with Beh\u00e7et's uveitis refractory to conventional treatments. Ophthalmology 117, 1430\u20131435 (2010).","journal-title":"Ophthalmology"},{"key":"BFnrrheum2012156_CR90","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/archophthalmol.2011.3","volume":"129","author":"S Onal","year":"2011","unstructured":"Onal, S. et al. Long-term efficacy and safety of low-dose and dose-escalating interferon \u03b12a therapy in refractory Beh\u00e7et uveitis. Arch. Ophthalmol. 129, 288\u2013294 (2011).","journal-title":"Arch. Ophthalmol."},{"key":"BFnrrheum2012156_CR91","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.semarthrit.2003.09.005","volume":"33","author":"I K\u00f6tter","year":"2004","unstructured":"K\u00f6tter, I. et al. Differential efficacy of human recombinant interferon-\u03b12a on ocular and extraocular manifestations of Beh\u00e7et disease: results of an open 4-center trial. Semin. Arthritis Rheum. 33, 311\u2013319 (2004).","journal-title":"Semin. Arthritis Rheum."},{"key":"BFnrrheum2012156_CR92","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/0-306-48382-3_117","volume":"528","author":"H Kikuchi","year":"2003","unstructured":"Kikuchi, H., Aramaki, K. & Hirohata, S. Low dose MTX for progressive neuro-Beh\u00e7et's disease. A follow-up study for 4 years. Adv. Exp. Med. Biol. 528, 575\u2013578 (2003).","journal-title":"Adv. Exp. Med. Biol."},{"key":"BFnrrheum2012156_CR93","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2177\/jsci.22.13","volume":"22","author":"H Suda","year":"1999","unstructured":"Suda, H. Low-dose weekly methotrexate therapy for progressive neuro-Beh\u00e7et's disease [Japanese]. Nihon Rinsho Meneki Gakkai Kaishi 22, 13\u201322 (1999).","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"},{"key":"BFnrrheum2012156_CR94","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.neurol.2011.09.006","volume":"168","author":"EH Ait Ben Haddou","year":"2012","unstructured":"Ait Ben Haddou, E. H. et al. Neurological manifestations of Beh\u00e7et's disease: evaluation of 40 patients treated by cyclophosphamide. Rev. Neurol. (Paris) 168, 344\u2013349 (2012).","journal-title":"Rev. Neurol. (Paris)"},{"key":"BFnrrheum2012156_CR95","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1007\/s10067-005-0070-8","volume":"25","author":"I K\u00f6tter","year":"2006","unstructured":"K\u00f6tter, I. et al. CNS involvement occurs more frequently in patients with Beh\u00e7et's disease under cyclosporin A (CSA) than under other medications\u2014results of a retrospective analysis of 117 cases. Clin. Rheumatol. 25, 482\u2013486 (2006).","journal-title":"Clin. Rheumatol."},{"key":"BFnrrheum2012156_CR96","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1136\/jnnp.64.3.382","volume":"64","author":"S Farah","year":"1998","unstructured":"Farah, S. et al. Beh\u00e7et's syndrome: a report of 41 patients with emphasis on neurological manifestations. J. Neurol. Neurosurg. Psychiatry 64, 382\u2013384 (1998).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrrheum2012156_CR97","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jvs.2005.03.019","volume":"42","author":"A Hosaka","year":"2005","unstructured":"Hosaka, A. et al. Long-term outcome after surgical treatment of arterial lesions in Beh\u00e7et disease. J. Vasc Surg. 42, 116\u2013121 (2005).","journal-title":"J. Vasc Surg."},{"key":"BFnrrheum2012156_CR98","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s10067-007-0685-z","volume":"27","author":"JK Ahn","year":"2008","unstructured":"Ahn, J. K., Lee, Y. S., Jeon, C. H., Koh, E. M. & Cha, H. S. Treatment of venous thrombosis associated with Beh\u00e7et's disease: immunosuppressive therapy alone versus immunosuppressive therapy plus anticoagulation. Clin. Rheumatol. 27, 201\u2013205 (2008).","journal-title":"Clin. Rheumatol."},{"key":"BFnrrheum2012156_CR99","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1136\/ard.2007.080432","volume":"67","author":"G Hatemi","year":"2008","unstructured":"Hatemi, G. et al. EULAR recommendations for the management of Beh\u00e7et disease. Ann. Rheum. Dis. 67, 1656\u20131662 (2008).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2012156_CR100","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1046\/j.1468-3083.2003.00760.x","volume":"17","author":"R Karlidag","year":"2003","unstructured":"Karlidag, R. et al. Stressful life events, anxiety, depression and coping mechanisms in patients with Beh\u00e7et's disease. J. Eur. Acad. Dermatol. Venereol. 17, 670\u2013675 (2003).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"BFnrrheum2012156_CR101","first-page":"721","volume":"66","author":"S Karatay","year":"2011","unstructured":"Karatay, S. et al. Vitamin D status in patients with Beh\u00e7et's disease. Clinics (Sao Paulo) 66, 721\u2013723 (2011).","journal-title":"Clinics (Sao Paulo)"},{"key":"BFnrrheum2012156_CR102","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/B978-0-12-386960-9.00014-9","volume":"86","author":"M Cutolo","year":"2011","unstructured":"Cutolo, M., Plebani, M., Shoenfeld, Y., Adorini, L. & Tincani, A. Vitamin D endocrine system and the immune response in rheumatic diseases. Vitam. Horm. 86, 327\u2013351 (2011).","journal-title":"Vitam. Horm."},{"key":"BFnrrheum2012156_CR103","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1136\/ard.2006.056630","volume":"66","author":"T Daikeler","year":"2007","unstructured":"Daikeler, T. et al. Haematopoietic stem cell transplantation for vasculitis including Beh\u00e7et's disease and polychondritis: a retrospective analysis of patients recorded in the European Bone Marrow Transplantation and European League Against Rheumatism databases and a review of the literature. Ann. Rheum. Dis. 66, 202\u2013207 (2007).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2012156_CR104","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3109\/s10165-011-0497-5","volume":"22","author":"T Hirano","year":"2012","unstructured":"Hirano, T. et al. A case of Beh\u00e7et's disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab. Mod. Rheumatol. 22, 298\u2013302 (2012).","journal-title":"Mod. Rheumatol."},{"key":"BFnrrheum2012156_CR105","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.mehy.2008.01.011","volume":"71","author":"A Borhani Haghighi","year":"2008","unstructured":"Borhani Haghighi, A. & Safari, A. Tocilizumab may be a potential addition to our weapons against neuro-Beh\u00e7et's disease. Med. Hypotheses 71, 156\u2013157 (2008).","journal-title":"Med. Hypotheses"},{"key":"BFnrrheum2012156_CR106","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.clineuro.2011.10.024","volume":"114","author":"LS Shapiro","year":"2012","unstructured":"Shapiro, L. S., Farrell, J. & Haghighi, A. B. Tocilizumab treatment for neuro-Beh\u00e7et's disease, the first report. Clin. Neurol. Neurosurg. 114, 297\u2013298 (2012).","journal-title":"Clin. Neurol. Neurosurg."},{"key":"BFnrrheum2012156_CR107","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1385\/CRIAI:29:3:295","volume":"29","author":"Z Tellier","year":"2005","unstructured":"Tellier, Z. Intravenous immunoglobulin in eye involvement. Clin. Rev. Allergy Immunol. 29, 295\u2013306 (2005).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"BFnrrheum2012156_CR108","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1136\/annrheumdis-2011-155143","volume":"71","author":"A G\u00fcl","year":"2012","unstructured":"G\u00fcl, A. et al. Interleukin-1\u03b2-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Beh\u00e7et's disease: an open-label pilot study. Ann. Rheum. Dis. 71, 563\u2013566 (2012).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2012156_CR109","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1093\/rheumatology\/38.8.728","volume":"38","author":"BB Bhakta","year":"1999","unstructured":"Bhakta, B. B. et al. Beh\u00e7et's disease: evaluation of a new instrument to measure clinical activity. Rheumatology (Oxford) 38, 728\u2013733 (1999).","journal-title":"Rheumatology (Oxford)"}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2012.156.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2012.156","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2012.156.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:30:13Z","timestamp":1684470613000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrrheum.2012.156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,25]]},"references-count":109,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["BFnrrheum2012156"],"URL":"https:\/\/doi.org\/10.1038\/nrrheum.2012.156","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,25]]}}}